MODUS THERAPEUTICS

modus-therapeutics-logo

Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
#SimilarOrganizations #People #Financial #Website #More

MODUS THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Clinical Trials Pharmaceutical Therapeutics

Founded:
2011-01-01

Address:
Stockholm, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.modustx.com

Total Employee:
1+

Status:
Active

Contact:
556669-2199

Email Addresses:
[email protected]

Total Funding:
183.5 M SEK

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Google Maps


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.


Current Advisors List

tomas-odergren_image

Tomas Odergren Board Member @ Modus Therapeutics
Board_member

mats-wahlgren_image

Mats Wahlgren Board Member @ Modus Therapeutics
Board_member

björn-sjöstrand_image

Björn Sjöstrand Chairman @ Modus Therapeutics
Board_member

torsten-goesch_image

Torsten Goesch Board Member @ Modus Therapeutics
Board_member

Current Employees Featured

ellen-wittmack-donnelly_image

Ellen Wittmack Donnelly
Ellen Wittmack Donnelly CEO @ Modus Therapeutics
CEO
2017-04-01

mats-wahlgren_image

Mats Wahlgren
Mats Wahlgren Co-Founder, Chief Scientific Officer @ Modus Therapeutics
Co-Founder, Chief Scientific Officer

thomas-knittel_image

Thomas Knittel
Thomas Knittel Chief Medical Officer @ Modus Therapeutics
Chief Medical Officer

lena-jendeberg_image

Lena Jendeberg
Lena Jendeberg Vice President, Development @ Modus Therapeutics
Vice President, Development

Founder


mats-wahlgren_image

Mats Wahlgren

Stock Details


Company's stock symbol is STO:MODTX

Investors List

karolinska_image

Karolinska

Karolinska investment in Post-IPO Debt - Modus Therapeutics

healthcap_image

HealthCap

HealthCap investment in Series A - Modus Therapeutics

rosetta-capital_image

Rosetta Capital

Rosetta Capital investment in Venture Round - Modus Therapeutics

praktikerinvest_image

Praktikerinvest

Praktikerinvest investment in Venture Round - Modus Therapeutics

kdev-investments_image

KDev Investments

KDev Investments investment in Venture Round - Modus Therapeutics

ostersjostiftelsen_image

Ostersjöstiftelsen

Ostersjöstiftelsen investment in Venture Round - Modus Therapeutics

Official Site Inspections

http://www.modustx.com Semrush global rank: 8.3 M Semrush visits lastest month: 335

  • Host name: 77.68.2.47
  • IP address: 77.68.2.47
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Modus Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved